CYTEK BIOSCIENCES, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2020 | — | $-42.5M | — |
| Jun 2020 | — | $-34.3M | $35.3M |
| Sep 2020 | — | $-27.4M | $35.5M |
| Dec 2020 | — | $-16.0M | $165.2M |
| Mar 2021 | — | $-14.8M | $168.6M |
| Jun 2021 | — | $-11.0M | $159.8M |
| Sep 2021 | — | $403.2M | $376.8M |
| Dec 2021 | — | $405.4M | $364.6M |
| Mar 2022 | — | $407.4M | $362.5M |
| Jun 2022 | — | $411.1M | $349.9M |
| Sep 2022 | — | $416.5M | $341.5M |
| Dec 2022 | — | $425.5M | $296.6M |
| Mar 2023 | — | $423.5M | $129.5M |
| Jun 2023 | — | $424.2M | $131.5M |
| Sep 2023 | — | $415.5M | $163.6M |
| Dec 2023 | — | $393.1M | $167.3M |
| Mar 2024 | — | $392.6M | $168.8M |
| Jun 2024 | — | $389.1M | $177.9M |
| Sep 2024 | — | $385.5M | $162.3M |
| Dec 2024 | — | $395.7M | $98.7M |
| Mar 2025 | — | $379.6M | $95.3M |
| Jun 2025 | — | $377.6M | $75.5M |
| Sep 2025 | — | $378.6M | $93.3M |
| Dec 2025 | — | $341.7M | $90.9M |
| Mar 2026 | — | $327.6M | $65.7M |
| Jun 2026 | — | $322.0M | $73.8M |